| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.797 | 22.376 | 15.166 | 14.235 | 25.717 | 4.432 | 105.558 | 30.804 | 101.429 | 35.026 |
| Total Income - EUR | 33.458 | 23.906 | 13.688 | 21.769 | 34.017 | 13.676 | 102.823 | 75.630 | 144.490 | 44.374 |
| Total Expenses - EUR | 25.030 | 19.417 | 15.014 | 21.069 | 28.272 | 26.140 | 45.653 | 169.186 | 217.729 | 108.999 |
| Gross Profit/Loss - EUR | 8.428 | 4.489 | -1.326 | 700 | 5.745 | -12.464 | 57.170 | -93.556 | -73.239 | -64.626 |
| Net Profit/Loss - EUR | 7.873 | 4.346 | -1.443 | 273 | 5.467 | -12.516 | 56.863 | -93.784 | -73.806 | -64.626 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Lauranis Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.478 | 21.667 | 88.115 | 76.040 | 64.311 | 53.991 | 85.763 | 76.601 | 60.097 | 22.577 |
| Current Assets | 36.833 | 34.564 | 36.117 | 38.115 | 49.798 | 53.075 | 104.471 | 334.331 | 304.888 | 345.135 |
| Inventories | 21.612 | 16.664 | 20.887 | 13.566 | 18.588 | 34.617 | 45.068 | 231.507 | 216.078 | 248.013 |
| Receivables | 10.526 | 11.745 | 11.721 | 13.421 | 17.821 | 18.091 | 27.674 | 89.868 | 80.245 | 86.416 |
| Cash | 4.695 | 6.155 | 3.509 | 11.128 | 13.389 | 368 | 31.729 | 12.956 | 8.564 | 10.706 |
| Shareholders Funds | 14.710 | 18.907 | 17.144 | 17.103 | 22.239 | 9.301 | 65.958 | -55.440 | -101.362 | -165.421 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.718 | 37.325 | 107.088 | 97.052 | 91.870 | 97.765 | 124.276 | 466.372 | 466.347 | 533.133 |
| Income in Advance | 4.882 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "146 - 146" | |||||||||
| CAEN Financial Year |
146
|
|||||||||
Comments - Lauranis Bio S.r.l.